TRANSLATE BIO, INC.
TBIO NASDAQ
10.02
-0.53
-5.02%
After Hours: 10.02 0 0.00% 16:50 05/17 EDT
Open
10.41
Prev Close
10.55
High
10.64
Low
9.56
Volume
205.24K
Avg Vol (3M)
226.41K
52 Week High
16.60
52 Week Low
4.810
% Turnover
0.48%
Market Cap
432.14M
1D
5D
1M
3M
1Y
5Y
Comments
No Data
Related
Global X S&P 500® Catholic Values ETFiShares MSCI EAFE ESG Optimized ETFMAM SoftwarePluristemWPCS IntlQuotientFirst FoundationAmeris BancorpStealthGasMDC PartnrsThe9 LtdNiceBancorpWaterstone FinlPepsiCoGladstone LandSimply Good FoodGCI LibertyPROVENTION BIO, INC.Palomar Holdings Inc
Webull offers TRANSLATE BIO, INC. TBIO stock price, real time market quotes, professional analyst ratings, and in-depth charts, You can share investing ideas in community to communicate with others and learn trading skills.
Company Profile
Translate Bio, Inc. is a messenger RNA, or mRNA, therapeutics company. The Company is developing medicines to treat diseases caused by protein or gene dysfunction. The Company is using its proprietary mRNA therapeutic platform, or MRT platform, and it create mRNA that encodes functional proteins. The mRNA is delivered to the target cell where the cell’s own machinery recognizes it and translates it, restoring or augmenting protein function to treat or prevent disease. The MRT product candidate for the lung, MRT5005, is designed to address the underlying cause of CF by delivering mRNA encoding fully functional CFTR protein to the lung epithelial cells through nebulization.
MORE >Recently
Name
Price
%Change